ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Ophthalmology

Top Ophthalmology Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EUGENIO CANDAL MD

Ophthalmology

9,193

$663K

1469
1423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

49%
prescriptions for brand name drugs

Avg: 52%

$72
Average prescription price

Avg: $69

DANIEL O'CONNOR M.D.

Ophthalmology

6,830

$369K

1237
1153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

49%
prescriptions for brand name drugs

Avg: 52%

$54
Average prescription price

Avg: $69

LAURA FINE MD

Ophthalmology

5,886

$516K

697
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 52%

$88
Average prescription price

Avg: $69

BENJAMIN QUAMINA M.D.

Ophthalmology

5,600

$446K

720
597 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 52%

$80
Average prescription price

Avg: $69

PETER ZACHARIA MD

Ophthalmology

5,348

$357K

699
653 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

44%
prescriptions for brand name drugs

Avg: 52%

$67
Average prescription price

Avg: $69

ELENA GELLER MD

Ophthalmology

5,313

$319K

1070
1028 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 52%

$60
Average prescription price

Avg: $69

BRADFORD SHINGLETON MD

Ophthalmology

5,310

$173K

1139
1101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 52%

$33
Average prescription price

Avg: $69

HUSAMUDDIN ANSARI M.D., PH.D.

Ophthalmology

5,255

$368K

807
754 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 52%

$70
Average prescription price

Avg: $69

PAMELA HENDERSON M.D.

Ophthalmology

4,717

$390K

694
557 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 52%

$83
Average prescription price

Avg: $69

C. DOUGLAS EVANS MD

Ophthalmology

4,688

$364K

996
959 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 52%

$78
Average prescription price

Avg: $69

JAMES HUNG MD

Ophthalmology

4,636

$349K

670
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 52%

$75
Average prescription price

Avg: $69

MICHAEL OATS MD

Ophthalmology

4,406

$417K

925
876 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 52%

$95
Average prescription price

Avg: $69

JOHN CONSTANTINE M.D.

Ophthalmology

4,396

$288K

666
594 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 52%

$66
Average prescription price

Avg: $69

CLAUDIA RICHTER MD

Ophthalmology

4,305

$274K

630
594 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 52%

$64
Average prescription price

Avg: $69

ANDREW JUSKO MD

Ophthalmology

4,204

$248K

724
594 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 52%

$59
Average prescription price

Avg: $69

SERGEY URMAN MD

Ophthalmology

4,145

$341K

575
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 52%

$82
Average prescription price

Avg: $69

BABAK ELIASSI-RAD MD

Ophthalmology

3,884

$294K

510
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 52%

$76
Average prescription price

Avg: $69

MARK LATINA MD

Ophthalmology

3,879

$357K

567
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 52%

$92
Average prescription price

Avg: $69

JORGE BOTERO M.D.

Ophthalmology

3,873

$314K

667
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 52%

$81
Average prescription price

Avg: $69

D. HALPERN PH.D., M.D.

Ophthalmology

3,861

$200K

425
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 52%

$52
Average prescription price

Avg: $69

DALE OATES M.D.

Ophthalmology

3,716

$230K

722
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 52%

$62
Average prescription price

Avg: $69

FRANK BERSON MD

Ophthalmology

3,716

$185K

537
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 52%

$50
Average prescription price

Avg: $69

LEONARDO VELAZQUEZ M.D.

Ophthalmology

3,698

$272K

746
630 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 52%

$73
Average prescription price

Avg: $69

DOMENIC STRAZZULLA M.D.

Ophthalmology

3,585

$301K

621
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 52%

$84
Average prescription price

Avg: $69

PAUL BEADE MD

Ophthalmology

3,571

$273K

586
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 52%

$76
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank